Urol. praxi. 2023;24(3):177-179 | DOI: 10.36290/uro.2023.069

Metastatic/multicentric renal epithelioid angiomyolipoma - clinical case report

MUDr. Ondřej Cempírek1, MUDr. Tomáš Málek1, MUDr. Roman Boháč2
1 Urologické oddělení, Nemocnice Havlíčkův Brod, p. o.
2 Patologické oddělení, Nemocnice Havlíčkův Brod, p. o.

Renal epithelioid angiomyolipoma (ReAML) is a rare subtype of angiomyolipoma. It is a benign kidney disease, in which cases of aggressive behavior and malignancy have been reported. These tumors represent 8% of operated kidney angiomyolipomas. Diagnosis is based on histological findings. The aim of this text is to review the information on this issue, the histological picture and the case report of a 42-year-old woman operated at our department who was found to have multicentric or metastatic involvement of the retroperitoneal lymph node.

Keywords: renal epithelioid angiomyolipoma, PECom, cathepsin K, mTOR.

Accepted: September 25, 2023; Published: October 2, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cempírek O, Málek T, Boháč R. Metastatic/multicentric renal epithelioid angiomyolipoma - clinical case report. Urol. praxi. 2023;24(3):177-179. doi: 10.36290/uro.2023.069.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Martignoni G, Pea M, Zampini C, et al. PEComas of the kidney and of the genitourinary tract. Seminars in Diagnostic Pathology. 2015;32(2):140-159. Go to original source... Go to PubMed...
    2. Vicens RA, Jensen CT, Korivi BR, Bhosale PR. Malignant renal epithelioid angiomyolipoma with liver metastasis after resection: a case report with multimodality imaging and review of the literature. Journal of Computer Assisted Tomography [Internet]. 2014 [cited 2023 Apr 13];38(4):574-577. Available from: https://pubmed.ncbi.nlm.nih.gov/24887578/. Go to original source... Go to PubMed...
    3. Lasri A, Touzani MA, Lahyani M, et al. Angiomyolipome rénal épithélioïde malin (AREM): à propos d'un cas rare. Pan African Medical Journal [Internet]. 2019 [cited 2023 Apr 13];33. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689830/. Go to original source... Go to PubMed...
    4. Yang J, Liang C, Yang L. Advancements in the diagnosis and treatment of renal epithelioid angiomyolipoma: a narrative review. The Kaohsiung Journal of Medical Sciences. 2022;38(10):925-932. Go to original source... Go to PubMed...
    5. Lattanzi M, Deng FM, Chiriboga LA, et al. Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy. Journal for ImmunoTherapy of Cancer. 2018;6(1). Go to original source... Go to PubMed...
    6. Kazmierski B, Deurdulian C, Tchelepi H, Grant EG. Applications of contrast-enhanced ultrasound in the kidney. Abdominal Radiology. 2017;43(4):880-898. Go to original source... Go to PubMed...
    7. Liu F, Yuan H, Li X, Tang J, Tian X, Ji K. A new management strategy for renal angiomyolipomas: superselective arterial embolization in combination with radiofrequency ablation. Annals of Translational Medicine [Internet]. 2019 Dec [cited 2022 Mar 23];7(23):766-766. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990007/. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.